Blood Research

Cited by CrossRef (6)

  1. Shih-Hsiang Chen, Jiann-Shiuh Chen, Shiann-Tarng Jou, Kang-Hsi Wu, Iou-Jih Hung, Jiunn-Ming Sheen, Meng-Yao Lu, Bow-Wen Chen, Tang-Her Jaing, Shih-Chung Wang, Ming-Tsan Lin, Te-Kau Chang, Hsi-Che Liu, Chao-Ping Yang. Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group. Leukemia & Lymphoma 2019;60:1942
    https://doi.org/10.1080/10428194.2018.1562182
  2. Yu-Tong Zhang, Li-Zhe Wang, Jian Chang. Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.832752
  3. Eric J. Lowe, Laurence Brugieres. Non-Hodgkin's Lymphoma in Childhood and Adolescence. 2022.
    https://doi.org/10.1007/978-3-030-11769-6_20
  4. A. S. Volkova, T. T. Valiev, N. A. Batmanova, S. A. Yuldasheva, Z. S. Gordeeva, S. L. Sabantsev, G. A. Aleskerova, I. V. Osipova, S. R. Varfolomeeva. ALCL Protocol of the DOIG Research Institute 2003: results of treatment of anaplastic large cell lymphoma in children in a comparative multicenter clinical trial. Gematologiâ i transfuziologiâ 2023;68:432
    https://doi.org/10.35754/0234-5730-2023-68-4-432-442
  5. Ling Huang, Fen Zhang, Jialong Zeng, Hanguo Guo, Sichu Liu, Xiaojuan Wei, Feili Chen, Xinmiao Jiang, Zhanli Liang, Yanhui Liu, Wenyu Li. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population. Ann Hematol 2018;97:149
    https://doi.org/10.1007/s00277-017-3166-8
  6. Changfei Qin, Yuhua Huang, Yanfen Feng, Min Li, Na Guo, Huilan Rao. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases. Diagn Pathol 2018;13
    https://doi.org/10.1186/s13000-018-0693-0
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd